research LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.
Zhuhai, Hong Kong
McLean, VA, United States
Addis Ababa, Ethiopia
Indianapolis, IN, United States